@article{Mitchell_E-2020_8171,
title = {It is unprecedented: trial management during the COVID-19 pandemic and beyond},
author = {Mitchell, E. and Ahmed, K. and Breeman, S. and Cotton, S. and Constable, L. and Ferry, G. and Goodman, K. and Hickey, H. and Meakin, G. and Mironov, K. and Quann, N. and Wakefield, N. and McDonald, A.},
month = {sep},
year = {2020},
abstract = {The COVID-19 pandemic has presented unique challenges for the clinical trial community, both in the rapid establishment of COVID-19 clinical trials and many existing non-COVID-19 studies either being temporarily paused (whether that is a complete pause or pause in some activities) and/or adapting their processes. Trial managers have played a key role in decision-making, undertaking risk assessments and adapting trial processes, working closely with other members of the research team. This article presents some of the ways in which trial management processes have been altered and the key role that trial managers have played. It has been born out of discussions between trial managers in the UK who are members of the UK Trial Managers’ Network (UKTMN), a national network of trial management professionals managing non-commercial trials.},
volume = {21},
journal = {BMC Trials},
publisher = {Springer Nature},
url = {https://doi.org/10.1186/s13063-020-04711-6},
}
